HomeCVKD • NASDAQ
add
Cadrenal Therapeutics Ord Shs
Previous close
$14.51
Day range
$14.50 - $15.06
Year range
$5.40 - $32.55
Market cap
15.46M USD
Avg Volume
47.11K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.47M | 140.37% |
Net income | -2.39M | -138.58% |
Net profit margin | — | — |
Earnings per share | -2.25 | — |
EBITDA | -2.47M | -140.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.04M | 55.96% |
Total assets | 5.46M | 53.33% |
Total liabilities | 1.46M | 282.38% |
Total equity | 3.99M | — |
Shares outstanding | 1.07M | — |
Price to book | 3.88 | — |
Return on assets | -98.62% | — |
Return on capital | -120.81% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -2.39M | -138.58% |
Cash from operations | -1.53M | -92.28% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -1.53M | -91.50% |
Free cash flow | -677.79K | -77.03% |
About
Founded
2022
Website
Employees
4
